Cytosorbents (CTSO) Accounts Payables (2010 - 2026)
Cytosorbents posted quarterly Accounts Payables of $3.1 million for Q1 2026, down 5.82% year-on-year from $3.3 million in Q1 2025, and up 9.17% on a QoQ basis from $2.9 million in Q4 2025.
Cytosorbents (CTSO) has 17 years of Accounts Payables data on file, last reported at $3.1 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables fell 5.82% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $3.1 million (down 5.82% YoY), and the FY2025 full-year result was $2.9 million, down 14.1% from the prior year.
- Accounts Payables for Q1 2026 stood at $3.1 million, up from $2.9 million in the prior quarter.
- Across five years, Accounts Payables topped out at $4.8 million in Q1 2022 and bottomed at $1.7 million in Q4 2022.
- The 5-year median for Accounts Payables is $3.0 million (2025), against an average of $3.0 million.
- Peak annual rise in Accounts Payables reached 187.66% in 2022, while the deepest fall reached 41.0% in 2022.
- A 5-year view of Accounts Payables shows it stood at $1.7 million in 2022, then soared by 129.71% to $3.8 million in 2023, then declined by 12.16% to $3.3 million in 2024, then slipped by 14.1% to $2.9 million in 2025, then gained by 9.17% to $3.1 million in 2026.
- The last three Accounts Payables figures came in at $3.1 million (Q1 2026), $2.9 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.57 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.33 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 338.80 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | 3.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.13 Mn |
| Dec 31, 2025 | 2.87 Mn |
| Sep 30, 2025 | 3.04 Mn |
| Jun 30, 2025 | 3.39 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 3.80 Mn |
| Sep 30, 2023 | 3.44 Mn |
| Jun 30, 2023 | 2.84 Mn |
| Mar 31, 2023 | 2.99 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 2.35 Mn |
| Jun 30, 2022 | 2.13 Mn |
| Mar 31, 2022 | 4.83 Mn |
| Dec 31, 2021 | 2.81 Mn |
| Sep 30, 2021 | 3.36 Mn |
| Jun 30, 2021 | 2.17 Mn |
| Mar 31, 2021 | 1.68 Mn |
| Dec 31, 2020 | 1.84 Mn |
| Sep 30, 2020 | 2.39 Mn |
| Jun 30, 2020 | 2.73 Mn |
| Mar 31, 2020 | 1.77 Mn |
| Dec 31, 2019 | 2.04 Mn |
| Sep 30, 2019 | 2.07 Mn |
| Jun 30, 2019 | 2.15 Mn |
| Mar 31, 2019 | 1.84 Mn |
| Dec 31, 2018 | 1.49 Mn |
| Sep 30, 2018 | 1.86 Mn |
| Jun 30, 2018 | 1.25 Mn |
| Mar 31, 2018 | 2.14 Mn |
| Dec 31, 2017 | 1.24 Mn |
| Sep 30, 2017 | 1.29 Mn |
| Jun 30, 2017 | 1.58 Mn |
| Mar 31, 2017 | 1.66 Mn |
| Dec 31, 2016 | 1.33 Mn |
| Sep 30, 2016 | 739,940.00 |
| Jun 30, 2016 | 1.02 Mn |
| Mar 31, 2016 | 860,692.00 |
| Dec 31, 2015 | 684,633.00 |
| Dec 31, 2014 | 698,307.00 |
| Sep 30, 2014 | 446,167.00 |
| Jun 30, 2014 | 525,957.00 |
| Mar 31, 2014 | 527,647.00 |
| Dec 31, 2013 | 786,517.00 |
| Sep 30, 2013 | 572,014.00 |
| Jun 30, 2013 | 720,560.00 |
| Mar 31, 2013 | 704,710.00 |
| Dec 31, 2012 | 800,670.00 |
| Sep 30, 2012 | 728,011.00 |
| Jun 30, 2012 | 620,845.00 |
| Mar 31, 2012 | 647,522.00 |
| Dec 31, 2011 | 675,160.00 |
| Sep 30, 2011 | 784,357.00 |
| Jun 30, 2011 | 832,620.00 |
| Dec 31, 2010 | 817,701.00 |